A comparative study of policosanol versus pravastatin in patients with type II hypercholesterolemia

This publication has 28 references indexed in Scilit:

• Treatment of Hypercholesterolemia in NIDDM With Policosanol
  Diabetes Care, 1995
• Toxicity of policosanol in beagle dogs: one-year study
  Toxicology Letters, 1994
• Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase
  The American Journal of Cardiology, 1994
• Carcinogenicity of policosanol in sprague dawley rats: A 24 month study
  Teratogenesis, Carcinogenesis, and Mutagenesis, 1994
• Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors
  The American Journal of Cardiology, 1993
• Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction
  The American Journal of Cardiology, 1993
• Pravastatin
  Drugs, 1991
• Efficacy and safety of pravastatin in patients with primary hypercholesterolemia
  Atherosclerosis, 1990
• An Overview of Lipid-Lowering Drugs
  Drugs, 1988
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987